AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2012
Apr 16, 2012
35334_dirs_2012-04-16_a9a4bfdb-2201-4316-8950-fc048c74648d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2012-04-13
Reporting Person: CARTER WILLIAM A (Director, CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-04-13 | Options to buy Common Stock | $4.03 | J | 10000 | Acquired | 2022-04-13 | Common Stock (10000) | Direct |
Footnotes
F1: Replacement of expired option to purchase common stock.
More from AIM ImmunoTech Inc.
Governance Information
2026
Jun 10
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14